Fundraising Fox
Surgical Innovation Associates
Chicago, US · Delaware corporation · 3 known investors
Find your way into Surgical Innovation Associates
Sign up to see every warm intro you have to Surgical Innovation Associates
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Surgical Innovation Associates team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Commercializing improved resorbable surgical mesh as a safer and less expensive alternative for soft tissue support
Founders & leadership
JO
Jason O'HearnChief Commercial Officer
JS
John SlumpChief Financial Officer2018–2022John Slump is Chief Financial Officer of Surgical Innovation Associates, which commercializes resorbable surgical mesh for soft tissue support. He has held executive roles at multiple medical device companies that were acquired by larger firms, including SIA (acquired by Integra), Attune Medical (acquired by Haemonetics), and Farapulse (acquired by Boston Scientific).
JY
John Y.S. Kim, M.D.Named on SEC filing
Board
RE
Ryan EgelandBoard director
Investors · 3
First Leaf Capitallisted by First Leaf CapitalChampaign-Urbanavia Mark Aardsma · inferred
How we know: First Leaf Capital's portfolio page · Not right? Tell us
Funding
SEC filings, press & company announcements$8.9M disclosed across 5 of 6 rounds · 2016–2022
- Undisclosed amountSeries BMar 2022Source ↗
▶$4.8MraisedApr 2021 · 59 investors · Other Health CareRule 506(b)
▶$4.8MraisedApr 2021 · 59 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason O'HearnExecutive Officer
- Ryan EgelandDirector
- John Y.S. Kim, M.D.Director
- Alexei MlodinowExecutive Officer, Director
- John SlumpExecutive Officer
- Todd CruikshankExecutive Officer
- Amount sold
- $4.8M
- Minimum investment
- $50K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedJun 2020 · 39 investors · Other Health CareRule 506(b)
▶$1.7MraisedJun 2020 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John Y.S. Kim, M.D.Director
- Ryan EgelandDirector
- Alexei MlodinowExecutive Officer, Director
- Todd CruikshankExecutive Officer
- John SlumpExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.7M
- Proceeds to insiders
- $541.1K
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.3MraisedApr 2019 · 15 investors · Other Health CareRule 506(b)
▶$1.3MraisedApr 2019 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Todd CruikshankExecutive Officer
- Alexei MlodinowExecutive Officer, Director
- John Y.S. Kim, M.D.Director
- Offering amount
- $4M
- Amount sold
- $1.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$325KraisedMar 2018 · 3 investors · Other Health CareRule 506(b)
▶$325KraisedMar 2018 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexei MlodinowExecutive Officer, Director
- Todd CruikshankExecutive Officer
- John Y.S. Kim, M.D.Director
- Offering amount
- $1.5M
- Amount sold
- $325K
- Minimum investment
- $10K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$748KraisedJul 2017 · 18 investors · Other Health CareRule 506(b)
▶$748KraisedJul 2017 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexei MlodinowExecutive Officer, Director
- John Y.S. Kim, M.D.Director
- Todd CruikshankExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $748K
- Minimum investment
- $10K
- Proceeds to insiders
- $60K
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Surgical Innovation Associates do?
- Commercializing improved resorbable surgical mesh as a safer and less expensive alternative for soft tissue support
- Who founded Surgical Innovation Associates?
- Surgical Innovation Associates was founded by Alexei Mlodinow.
- Who are Surgical Innovation Associates's investors?
- Surgical Innovation Associates's investors include First Leaf Capital, Harvard Business Angels of Chicago, Harvard Business School Alumni Angels of Greater New York.
- How much funding has Surgical Innovation Associates raised?
- Surgical Innovation Associates has disclosed $8.9M raised across 5 of its 6 known rounds.
- Where is Surgical Innovation Associates headquartered?
- Surgical Innovation Associates is headquartered in Chicago, US.